1. Home
  2. BZAIW vs GRMLW Comparison

BZAIW vs GRMLW Comparison

Compare BZAIW & GRMLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blaize Holdings Inc. Warrants

BZAIW

Blaize Holdings Inc. Warrants

HOLD

Current Price

$0.53

Market Cap

0.0

Sector

N/A

ML Signal

HOLD

GRMLW

Greenland Mines Ltd Warrant

N/A

Current Price

$0.18

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BZAIW
GRMLW
Founded
2010
N/A
Country
United States
United States
Employees
254
5
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BZAIW
GRMLW
Price
$0.53
$0.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
66.5K
10.3K
Earning Date
05-14-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,967,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.10
52 Week High
$1.50
$0.37

Technical Indicators

Market Signals
Indicator
BZAIW
GRMLW
Relative Strength Index (RSI) 58.08 58.22
Support Level $0.46 $0.12
Resistance Level $0.61 $0.23
Average True Range (ATR) 0.09 0.05
MACD 0.01 0.00
Stochastic Oscillator 66.17 23.62

Price Performance

Historical Comparison
BZAIW
GRMLW

About BZAIW Blaize Holdings Inc. Warrants

Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.

About GRMLW Greenland Mines Ltd Warrant

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Share on Social Networks: